PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor

NCT06014385 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped lack of enrollment

Conditions

Muscarinic Receptor Occupancy

Interventions

DRUG: Scopolamine
RADIATION: [11C]EMO ([11C]LSN3172176)

Sponsor

Yale University

Collaborators

[object Object]